Literature DB >> 10768605

Acquired neuromyotonia: a new autoantibody-mediated neuronal potassium channelopathy.

I K Hart1.   

Abstract

Neuromyotonia (Isaacs syndrome) is a rare and heterogenous syndrome of continuous motor unit activity of peripheral nerve origin that manifests as various combinations of muscle stiffness, cramps, twitching, weakness, and delayed muscle relaxation. Although neuromyotonia may accompany an assortment of inherited diseases, most cases are acquired. The observation that the acquired form is often associated with an autoimmune disorder, and the demonstration that some cases improve after plasma exchange, has led to a search for an immune-mediated etiology. This review summarizes the recent immunological and electrophysiological evidence that autoantibodies to voltage-gated potassium channels produce the peripheral motor nerve hyperexcitability that characterizes neuromyotonia and thus establishes acquired neuromyotonia as an autoantibody-mediated disorder. In the nervous system, ion channels and neurotransmitter receptors that function as ligand-gated ion channels seem to be favored targets for autoantibody attack, and neuromyotonia can now be added to the growing list of autoimmune channelopathies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10768605     DOI: 10.1097/00000441-200004000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  6 in total

1.  Focal neuromyotonia: do I love you?

Authors:  A R Gantenbein; M Wiederkehr; C Meuli-Simmen; G Schwegler
Journal:  J Neurol       Date:  2010-06-09       Impact factor: 4.849

Review 2.  Positive muscle phenomena--diagnosis, pathogenesis and associated disorders.

Authors:  Hans G Kortman; Jan H Veldink; Gea Drost
Journal:  Nat Rev Neurol       Date:  2012-01-24       Impact factor: 42.937

3.  Metabolomic profile overlap in prototypical autoimmune humoral disease: a comparison of myasthenia gravis and rheumatoid arthritis.

Authors:  Derrick Blackmore; Liang Li; Nan Wang; Walter Maksymowych; Elaine Yacyshyn; Zaeem A Siddiqi
Journal:  Metabolomics       Date:  2020-01-04       Impact factor: 4.290

Review 4.  Using Xenopus oocytes in neurological disease drug discovery.

Authors:  Steven L Zeng; Leland C Sudlow; Mikhail Y Berezin
Journal:  Expert Opin Drug Discov       Date:  2019-11-01       Impact factor: 6.098

5.  Neuromyotonia: A Sequel to Indigenous Medication.

Authors:  Laxmi Khanna; Chandrashekar Agrawal; Mandaville Gourie-Devi; Ankkita S Bhandari
Journal:  Ann Indian Acad Neurol       Date:  2022-06-24       Impact factor: 1.714

6.  Mercury Toxicity Following Unauthorized Siddha Medicine Intake - A Mimicker of Acquired Neuromyotonia - Report of 32 Cases.

Authors:  G Gnanashanmugam; R Balakrishnan; S P Somasundaram; N Parimalam; P Rajmohan; M B Pranesh
Journal:  Ann Indian Acad Neurol       Date:  2018 Jan-Mar       Impact factor: 1.383

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.